Skip to main content

Correction to: Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner

The Original Article was published on 29 October 2018

Correction to: J Exp Clin Cancer Res 37, 260 (2018)

https://doi.org/10.1186/s13046-018-0932-y

Following publication of the original article [1], the authors identified minor errors in Fig. 5; specifically, in Fig. 5c, the label ‘Tumor free (%)’ was used. The correct label is ‘Tumor-bearing mice (%)’. The corrected figure is provided here; the figure caption has been corrected to reflect the same.

Fig. 5
figure1

Long-term LNT treatments induce regression of LAP0297 lung cancer. LAP0297 lung cancer-bearing mice were prepared as described in Fig. 1. When tumors reached 4 × 4 mm in diameter, mice were randomly divided into 2 groups and received i.p. injection of saline or LNT (1.0 mg/kg) for 1 month. a Representative photographs of LAP0297 lung cancer-bearing mice in saline and LNT-treated group were taken at the end of the experiment. b The growth curves of LAP0297 lung cancer upon long-term therapy of saline or LNT. c The percentage of tumor-bearing mice on day 45 after tumor inoculation (NS group, n = 17 mice, LNT-treated group, n = 24 mice). *** p < 0.001

In addition, the Competing Interests section of the article has been corrected as follows:

Competing interests

Guoxi Zhang is an employee of Nanjing Luye Pharmaceutical Co., Ltd (Nanjing, China) and provided the main research subject (Lentinan) of the study. The other authors declare that they have no competing interests.

The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.

Reference

  1. 1.

    Deng S, Zhang G, Kuai J, et al. Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner. J Exp Clin Cancer Res. 2018;37:260 https://doi.org/10.1186/s13046-018-0932-y.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Qunli Wu or Yuhui Huang.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Deng, S., Zhang, G., Kuai, J. et al. Correction to: Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner. J Exp Clin Cancer Res 40, 366 (2021). https://doi.org/10.1186/s13046-021-02170-8

Download citation